PharmaCyte Biotech
PMCB
PMCB
23 hedge funds and large institutions have $632K invested in PharmaCyte Biotech in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.6K | |
| 2 | +$10.1K | |
| 3 | +$763 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$511 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$363 |
Top Sellers
| 1 | -$13.6K | |
| 2 | -$712 | |
| 3 | -$78 | |
| 4 |
JPMorgan Chase & Co
New York
|
-$20 |
| 5 |
BlackRock
New York
|
-$18 |
